6,678 trials
Volume Restoration and Shaping of the Buttocks
Primary: Percentage of Participants With Improvement on the Global Esthetic Improvement Scale (GEIS) at Month 6 — 80.4 percentage of participants
Cardiac Arrest · Postresuscitation Syndrome · Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)
Primary: VerifyNow P2Y12Test - Platelet Reactivity — 238; 101 PRU
Pulmonary Hypertension
Primary: Absolute Change From Baseline Right Ventricular Ejection Fraction (the Unit is Percentage) — 7.56; -3.99 percentage
Type 2 Diabetes
Primary: Change From Baseline in Total Score for All Question Items in the Diabetes Therapy Related -QOL (DTR-QOL) Questionnaire at the End of Study — 8.72; 6.35 Units on a Scale…
Glaucoma
Primary: Mean Change From Baseline in Diurnal IOP at Week 6
HIV-1 Infection
Primary: The Proportion of Patients Who Can Achieve of Less Than 20 HIV RNA Copies Per ml at Week 48 of Both Arms. — 41; 36 Participants
Actinic Keratosis
Primary: Number of Participants With Adverse Events — 12; 11; 6; 3 Participants
Asthma
Primary: Change in Forced Expiratory Volume in One Second (FEV1) % — 3.6; 5 Percentage of FEV1
Type 2 Diabetes
Primary: Glucagon Counterregulation to Hypoglycemia — 16.0; 16.5 pmol/l
Retinal Vein Occlusion · Age Related Macular Degeneration
Primary: Mean Change From Baseline in Best Correct Visual Acuity (BCVA) — 9.55 Letters
Parkinson´s Disease
Primary: Change From Baseline to Visit 2 in Unified Parkinson's Disease Rating Scale (UPDRS) Part III Motor Score — -1.0; -5.3 Scores on a scale — p==0.134
Acne Vulgaris · Post Inflammatory Hyperpigmentation
Primary: Investigator Global Assessment Scale for Severity of Facial Acne — 0; 0; 11; 9 Participants
Diabetic Macular Edema
Primary: Mean Change in Central 1 mm Subfield Thickness Between Baseline and 9 Months — -51; -60 millimeters
Measles Antibody Seroconversion · Rubella Antibody Seroconversion · Rotavirus Geometric Mean Titer (GMT)
Primary: Percentage/Number of Subjects With Seroprotection for Measles Virus Serum Neutralization Antibodies — 171; 173; 56; 60 Participants
Pain, Postoperative
Primary: Assessing Change in Pain Using the Visual Analogue Scale (VAS) Pain Score — 2.90; 3.51; 2.36; 2.40 score on a scale